aripiprazole · Otsuka · NDA 207202
Abilify Mycite Kit
Earliest generic entry, as listed · earliest of 6 marketed strengths
15 Oct 2033
No marketed reference-listed strength; date taken from all listed strengths.
Blocked by patent: US 9268909.
Listed patents · 24 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 9268909 | drug product, use U-2168 · sets the listed date | 15 Oct 2033 |
| US 10517507 | drug product | 13 Jun 2032 |
| US 9320455 | drug product | 15 Dec 2031 |
| US 11229378 | drug product | 11 Jul 2031 |
| US 8547248 | drug product, use U-2167 | 18 Dec 2030 |
| US 8258962 | drug product | 25 Nov 2030 |
| US 8961412 | drug product | 17 Nov 2030 |
| US 9941931 | drug product | 4 Nov 2030 |
| US 11464423 | drug product | 15 Sep 2030 |
| US 8114021 | drug product | 21 Jun 2030 |
| US 8545402 | drug product | 27 Apr 2030 |
| US 8847766 | drug product, use U-2167 | 29 Mar 2030 |
| US 9149577 | drug product | 15 Dec 2029 |
| US 8718193 | drug product | 5 Dec 2029 |
| US 9433371 | drug product | 15 Sep 2029 |
| US 8945005 | drug product, use U-2167 | 19 Aug 2029 |
| US 10441194 | drug product | 26 Jul 2029 |
| US 8956288 | drug product, use U-2167 | 6 Jul 2029 |
| US 8674825 | drug product, use U-2170 | 9 Apr 2029 |
| US 9060708 | drug product | 5 Mar 2029 |
| US 9258035 | drug product | 5 Mar 2029 |
| US 9119554 | drug product | 16 Dec 2028 |
| US 9444503 | drug product, use U-2169 | 19 Nov 2027 |
| US 8759350 | use U-1529 | 2 Mar 2027 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 6
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 207202 · 001 · RLD · discontinued | tablet, oral | 2MG | 15 Oct 2033 |
| 207202 · 002 · RLD · discontinued | tablet, oral | 5MG | 15 Oct 2033 |
| 207202 · 003 · RLD · discontinued | tablet, oral | 10MG | 15 Oct 2033 |
| 207202 · 004 · RLD · discontinued | tablet, oral | 15MG | 15 Oct 2033 |
| 207202 · 005 · RLD · discontinued | tablet, oral | 20MG | 15 Oct 2033 |
| 207202 · 006 · RLD · discontinued | tablet, oral | 30MG | 15 Oct 2033 |
Expired or delisted (3)
- US 7978064 · product · 14 Sep 2026
- US 9125939 · use U-1749 · 28 Jul 2026
- US 11476952 · product · 28 Apr 2026